☆ 4.6 Article

Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles

NPJ VACCINES (2023)

Related references

Note: Only part of the references are listed.

Article Virology

The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus

Wenjuan Dong et al.

Summary: The K18-hACE2 mouse model provides a comprehensive analysis of SARS-CoV-2 infection and shows that different viral doses lead to varying degrees of organ damage. This model accurately reproduces both severe and non-severe COVID-19 in humans, making it valuable for drug development.

JOURNAL OF VIROLOGY (2022)

Add to Collection

Review Immunology

Tissue resident memory T cells in the respiratory tract

Ming Z. M. Zheng et al.

Summary: Tissue-resident memory (Trm) cells in the respiratory tract play a crucial role in local immune responses against infections. Factors influencing the development, longevity, and immune surveillance of Trm cells were discussed, along with vaccination regimes harnessing these cells as new strategies to combat future global pandemics.

MUCOSAL IMMUNOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants

David W. Eyre et al.

Summary: In this study, it was found that vaccination reduces the transmission risk of the Delta variant, but the protection of the vaccine decreases over time. The effectiveness of the vaccine is higher against the Alpha variant compared to the Delta variant.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Virology

Strong SARS-CoV-2 N-Specific CD8+ T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice

Flavia Ferrantelli et al.

Summary: Engineered extracellular vesicles can induce a potent SARS-CoV-2 CD8(+) T cell immune response and generate long-lasting lung-specific immune memory. This immunization approach is significant in addressing the limitations of current anti-SARS-CoV-2 vaccines.

VIRUSES-BASEL (2022)

Add to Collection

Article Multidisciplinary Sciences

Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts

Rhia Kundu et al.

Nature Communications (2022)

Add to Collection

Article Environmental Sciences

UltraViolet SANitizing System for Sterilization of Ambulances Fleets and for Real-Time Monitoring of Their Sterilization Level

Zuleika Michelini et al.

Summary: This study utilizes a UV-SAN system with UVC radiation to sanitize ambulances, showing that it efficiently eliminates SARS-CoV-2 virus and multi drug resistant bacteria, providing a rapid, efficient, and sustainable method for ambulance sanitization.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Add to Collection

Article Medicine, General & Internal

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients

Lorenzo Azzi et al.

Summary: BNT162b2 COVID-19 vaccine induces strong systemic immune response but poorly activates mucosal immunity.

EBIOMEDICINE (2022)

Add to Collection

Article Immunology

Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion

Valeria Fumagalli et al.

Summary: In this study, researchers described a method using an inhalation tower system to expose unanesthetized transgenic mice to aerosolized virus. This approach has advantages in simulating COVID-19 pathogenesis and provides a useful tool for studying viral transmission, disease pathogenesis, and therapeutic interventions.

SCIENCE IMMUNOLOGY (2022)

Add to Collection

Article Virology

Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse

Frauke Seehusen et al.

Summary: SARS-CoV-2 not only affects the respiratory tract but also causes neurological symptoms and neuroinflammation. Using transgenic mice, it was found that various SARS-CoV-2 variants can spread to the central nervous system (CNS) following intranasal infection and primarily infect neurons. The inflammatory response is mainly driven by microglia and immune cells, and microglia may play a significant role in the pathology and viral effects of COVID-19.

VIRUSES-BASEL (2022)

Add to Collection

Article Virology

Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression

Mariano Carossino et al.

Summary: This study evaluated the pathogenesis and clinical dynamics of SARS-CoV-2 infection in a transgenic mouse model. The results suggest that the model has limitations in replicating the pathological processes, neuroinvasion, and neurodissemination observed in humans.

VIRUSES-BASEL (2022)

Add to Collection

Article Virology

Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice

Janhavi Prasad Natekar et al.

Summary: This study evaluated the pathogenesis of different variants of SARS-CoV-2 in mice expressing human ACE-2. The B.1.1.7, B.1.351, and B.1.617.2 variants were found to be more lethal and resulted in higher viral titers in the lungs and brain compared to the original B.1 strain. Interestingly, the B.1.1.529 variant showed less severe clinical signs and higher survival rates. Transcription levels of cytokines and chemokines were lower in mice infected with B.1 and B.1.1.529 compared to other variants.

VIRUSES-BASEL (2022)

Add to Collection

Article Immunology

Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant

Charlotte B. Acharya et al.

Summary: There was no significant difference in cycle threshold values between vaccinated and unvaccinated individuals infected with severe acute respiratory syndrome coronavirus 2 Delta, regardless of symptoms. Due to a substantial proportion of asymptomatic vaccine breakthrough cases with high viral levels, interventions such as masking and testing should be considered in settings with elevated coronavirus disease 2019 transmission.

OPEN FORUM INFECTIOUS DISEASES (2022)

Add to Collection

Editorial Material Medicine, General & Internal

SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative

Eli Y. Adashi et al.

MAYO CLINIC PROCEEDINGS (2022)

Add to Collection

Article Multidisciplinary Sciences

A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection

Iris N. Pardieck et al.

Summary: Repeated booster vaccinations with a three dose regimen of a synthetic peptide vaccine significantly enhance the CD8(+) T cell response, leading to protection against lethal SARS-CoV-2 infection. Understanding the mechanisms and impact of booster vaccinations is crucial for vaccine design and delivery.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Engineering, Biomedical

Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine

Zhenzhen Wang et al.

Summary: Researchers have developed an inhalable and room-temperature-stable virus-like particle COVID-19 vaccine that induces systemic and mucosal immune responses in small animals. The vaccine, consisting of a recombinant SARS-CoV-2 receptor-binding domain conjugated to lung-derived exosomes, enhanced the retention of the receptor-binding domain in the respiratory airway and lungs, and cleared SARS-CoV-2 pseudovirus in mice. In hamsters, the vaccine attenuated severe pneumonia and reduced inflammatory infiltrates after a challenge with live SARS-CoV-2.

NATURE BIOMEDICAL ENGINEERING (2022)

Add to Collection

Article Immunology

Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination

Jinyi Tang et al.

Summary: SARS-CoV-2 mRNA vaccination induces strong immune responses in the circulation, but its effectiveness in the respiratory tract, especially against variants of concern like Omicron, is still uncertain. This study found lower neutralizing antibody responses in the respiratory tract of vaccinated individuals compared to COVID-19 convalescents, despite robust antibody responses in the blood. Vaccination also induced circulating B and T cell immunity, but these responses were absent in the respiratory tract. Mouse immunization experiments showed that systemic mRNA vaccination alone resulted in weak respiratory mucosal neutralizing antibody responses, but combining it with mucosal adenovirus-S immunization produced strong neutralizing antibody responses against both the ancestral virus and the Omicron variant. Overall, this study suggests that current COVID-19 vaccines are highly effective against severe disease, but provide limited protection against breakthrough infections, particularly by the Omicron sublineage.

SCIENCE IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein

Francesco Manfredi et al.

Summary: This study proposes an innovative strategy for anti-SARS-CoV-2 immune response using extracellular vesicles (EVs). By fusing SARS-CoV-2 N with Nef(mut) or a deletion mutant of Nef(mut), the researchers successfully induced immune responses in human cells. The findings demonstrate the potential of engineered EVs to elicit a strong immune response in human cells.

VACCINES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

How Do Anti-SARS-CoV-2 mRNA Vaccines Protect from Severe Disease?

Maurizio Federico

Summary: COVID-19 pathogenesis develops in two phases. mRNA vaccines have shown efficacy in containing the development of severe disease possibly by inhibiting alveolar macrophages and counteracting cytokine storm.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Microbiology

Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2

Wei-Chiao Huang et al.

Summary: The study demonstrates that intranasal administration of liposome-displayed SARS-CoV-2 receptor-binding domain (RBD) can induce antigen-specific immune responses in the lungs. Both intranasal and intramuscular immunization with sub-microgram doses of RBD liposomes provide full protection against lethal SARS-CoV-2 infection.

PATHOGENS (2022)

Add to Collection

Article Medicine, Research & Experimental

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection

Delphine Planas et al.

Summary: This study evaluated the duration of neutralizing antibody response after Pfizer BNT162b2 vaccination and found a significant reduction in neutralization efficacy against Omicron variants. Breakthrough infection led to a transient increase in neutralizing antibodies against Omicron subvariants, followed by a gradual decline after 5-6 months. Infection, but not vaccination, triggered a strong immunoglobulin A (IgA) response and detectable Omicron-neutralizing activity.

MED (2022)

Add to Collection

Article Materials Science, Multidisciplinary

Inhalable dry powder mRNA vaccines based on extracellular vesicles

Kristen D. Popowski et al.

Summary: Respiratory diseases are a major global burden, and the development of effective therapeutics is limited. Researchers have developed a stable inhalable form of extracellular vesicles that can effectively deliver drugs to the lungs and have shown promising results in vaccine applications.

MATTER (2022)

Add to Collection

Article Immunology

Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees

Micaela Garziano et al.

Summary: Oral mucosal immunity plays a crucial role in preventing and defending against SARS-CoV-2 infection. Research has shown that after receiving the SARS-CoV-2 vaccine, the virus neutralization activity in the oral cavity is significantly lower compared to that in the blood.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Cell Biology

Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses

Hiroshi Ishii et al.

Summary: This study investigates the efficacy of an intranasal vaccine and finds that it can result in NAbs-independent control of SARS-CoV-2 infection by inducing CD8(+) T cell responses.

CELL REPORTS MEDICINE (2022)

Add to Collection

Article Virology

Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice

Pratima Kumari et al.

Summary: The study demonstrated that SARS-CoV-2 infection can lead to neuroinvasion and encephalitis in K18-hACE2 mice, resulting in mortality. While the highest virus titers were observed in the lungs, high levels of infectious virus were also found in the brains of the infected mice. The severity of the disease in infected mice correlated with peak viral levels in the brain.

VIRUSES-BASEL (2021)

Add to Collection

Article Immunology

Simultaneous CD8+ T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs

Flavia Ferrantelli et al.

Summary: A new vaccination approach based on in vivo engineering of extracellular vesicles to induce CD8(+) T cytotoxic lymphocyte immunity, resulting in cross-presentation of antigens to prime antigen-specific CD8(+) T-cells and initiate immune responses against viruses.

VACCINES (2021)

Add to Collection

Article Oncology

Long-Term Antitumor CD8+ T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles

Flavia Ferrantelli et al.

Summary: The study demonstrates an innovative method to induce antigen-specific CD8(+) T cell immune response by in vivo engineering of extracellular vesicles. By expressing specific proteins through DNA vectors, immunogenic EVs are generated to combat HPV-related tumors with promising results.

CANCERS (2021)

Add to Collection

Article Immunology

Virus-Induced CD8+ T-Cell Immunity and Its Exploitation to Contain the SARS-CoV-2 Pandemic

Maurizio Federico

Summary: This article discusses the role of CD8(+) T cell immunity against SARS-CoV-2 in different vaccine formulations, highlighting its ability to complement the shortcomings of antibodies and have a positive effect on antiviral immunity. Furthermore, CD8(+) T cell immunity also maintains efficacy in the presence of viral protein mutations.

VACCINES (2021)

Add to Collection

Article Critical Care Medicine

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Zhe Xu et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Editorial Material Multidisciplinary Sciences

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

Yonggang Zhou et al.

NATIONAL SCIENCE REVIEW (2020)

Add to Collection

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Immunology

The establishment of resident memory B cells in the lung requires local antigen encounter

S. Rameeza Allie et al.

NATURE IMMUNOLOGY (2019)

Add to Collection

Article Biochemical Research Methods

An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens

Simona Anticoli et al.

BIOTECHNOLOGY JOURNAL (2018)

Add to Collection

Review Cell Biology

Shedding light on the cell biology of extracellular vesicles

Guillaume van Niel et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Add to Collection

Article Biochemical Research Methods

An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens

Simona Anticoli et al.

BIOTECHNOLOGY JOURNAL (2018)

Add to Collection

Article Nanoscience & Nanotechnology

Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation

Paola Di Bonito et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)

Add to Collection

Article Oncology

A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice

Prakash Gangadaran et al.

ONCOTARGET (2017)

Add to Collection

Article Immunology

Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses

Jincun Zhao et al.

IMMUNITY (2016)

Add to Collection

Article Cell Biology

Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting

Oscar P. B. Wiklander et al.

JOURNAL OF EXTRACELLULAR VESICLES (2015)

Add to Collection

Article Chemistry, Multidisciplinary

Dynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging Reporter

Charles P. Lai et al.

ACS NANO (2014)

Add to Collection

Article Biotechnology & Applied Microbiology

Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection

Yuki Takahashi et al.

JOURNAL OF BIOTECHNOLOGY (2013)

Add to Collection

Article Immunology

Cutting Edge: Intravascular Staining Redefines Lung CD8 T Cell Responses

Kristin G. Anderson et al.

JOURNAL OF IMMUNOLOGY (2012)

Add to Collection

Article Immunology

A strategy of antigen incorporation into exosomes: Comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles

Laura Lattanzi et al.

VACCINE (2012)

Add to Collection

Article Immunology

Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells

A. Sistigu et al.

VACCINE (2011)

Add to Collection

Article Virology

T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice

Jincun Zhao et al.

JOURNAL OF VIROLOGY (2010)

Add to Collection

Article Virology

Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus

Paul B. McCray et al.

JOURNAL OF VIROLOGY (2007)

Add to Collection

Article Virology

Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein

Y Zhi et al.

VIROLOGY (2005)

Add to Collection

Article Immunology

Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in mice

XP Liang et al.

VACCINE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.